18 year follow up study suggests high mortality risk from untreated sleep disordered breathing
Moderate-to-severe sleep apnea is independently associated with increased risk of mortality
Treatment of obstructive sleep apnea with CPAP may lower cardiovascular risk
A study found 16% of Australian commercial drivers suffer from obstructive sleep apnea and 60% have sleep-disordered breathing.
Read more about sleep disordered breathing.

S8 AutoSet Spirit™ II
Latest APAP device. Featuring
Easy-Breathe Technology™
Mirage Activa™ LT
Unequalled comfort
VPAP™ IV
Noninvasive bilevel pressure support.
Compact, quiet and comfortable

Swift™ LT
Less is more.
VPAP™ III ST-A QuickNav
Large screen. Easier than ever
H4i™
Superior humidity output ... seamlessly integrated
International Diabetes Federation (IDF) makes statement supporting reciprocal screening of all patients with type 2 diabetes or sleep apnea.
Learn more about the link between OSA and type 2 diabetes.
To get the most out of your treatment, read our FAQs.

Are you new to continuous positive airway pressure (CPAP) therapy or an existing user?
Become a member of sleepVantage to access information, support and expert advice
ResMed is a leading developer, manufacturer, and marketer of products for the diagnosis and treatment of sleep-disordered breathing.